Atrial Fibrillation
Atrial Fibrillation: in-depth guide to symptoms, causes, tests, treatment, and prevention for patients in India and the UAE - including how chronic inflammation, fatigue fit in.
Atrial Fibrillation is a long-term health condition that can affect energy, organ function, and future heart–metabolic risk. Understanding what drives it - and which symptoms are emergencies - helps you act with a licensed clinician rather than fragmented internet advice.
Atrial Fibrillation involves the heart muscle, valves, electrical system, or arteries that supply the heart and body. Most long-term cardiovascular disease in India and the UAE is driven by atherosclerosis - plaque built from years of high LDL particles, high blood pressure, diabetes, smoking, and inflammation. South Asians experience coronary events at younger average ages; Gulf populations combine high obesity and diabetes prevalence with excellent tertiary cardiac centres - prevention still saves more lives than late stents alone.
Chronic low-grade inflammation is one of the threads running through atrial Fibrillation - and it is often what links it to fatigue. Inflammation is measurable (hs-CRP, ESR and related markers), it is treatable, and it is routinely left unmeasured. Asking what is driving it usually gets further than treating each symptom in isolation.
Family clustering of diabetes, hypertension, and heart disease is common; if first-degree relatives are affected, screen earlier for problems related to atrial Fibrillation.
This guide covers symptoms, complications, causes, tests, treatment options, prevention, and daily living tips for readers in India and the UAE. It is educational and not a personal diagnosis.
Is it chronic?
Atrial Fibrillation is generally approached as a chronic condition. You may feel well between flares or while numbers are controlled, but the underlying risk often persists. Long-term plans combine monitoring, lifestyle measures, and medicines or procedures when needed. Remission or excellent control is possible for many metabolic diseases, yet maintenance remains part of care.
What happens in the body
Atrial Fibrillation involves the heart muscle, valves, electrical system, or arteries that supply the heart and body. Most long-term cardiovascular disease in India and the UAE is driven by atherosclerosis - plaque built from years of high LDL particles, high blood pressure, diabetes, smoking, and inflammation. South Asians experience coronary events at younger average ages; Gulf populations combine high obesity and diabetes prevalence with excellent tertiary cardiac centres - prevention still saves more lives than late stents alone.
Symptoms
- Chest pressure, tightness, or pain on exertion - sometimes radiating to the jaw, arm, or back
- Breathlessness, reduced walking distance, or needing extra pillows to sleep
- Palpitations, skipped beats, or a sense of rapid irregular heartbeat
- Ankle swelling, sudden weight gain from fluid, or abdominal bloating in heart-failure patterns
- Leg pain or cramping after a predictable walking distance (claudication) in peripheral artery disease
- Atypical symptoms in women and people with diabetes: nausea, profound fatigue, or jaw discomfort without classic crushing pain
- Fainting, near-fainting, or severe dizziness - especially with exertion
- Emergency pattern: pain lasting >15–20 minutes, cold sweat, collapse - call emergency services immediately
Effects & complications
- Heart attack, stroke, limb ischaemia, or sudden cardiac death depending on which arteries fail
- Progressive heart failure with repeated hospitalisations if pumping or filling function declines
- Atrial fibrillation raising clot and stroke risk
- Kidney injury from low forward flow or shared vascular disease (cardiorenal overlap)
- Reduced exercise capacity, sexual function impact, and anxiety about recurrence
- Need for lifelong secondary-prevention medicines after an event
- Procedures: stents, bypass, ablation, devices (pacemaker/ICD) in selected cases
- Economic and family burden of premature disease in working-age adults - especially relevant in South Asia
Causes & risk factors
- High LDL cholesterol and lifelong cholesterol-year exposure
- Hypertension damaging arterial walls and the heart muscle
- Type 2 diabetes and insulin resistance accelerating atherosclerosis
- Tobacco (including smokeless forms common in parts of India) and second-hand smoke
- Obesity, physical inactivity, and obstructive sleep apnoea
- Family history of premature coronary disease; South Asian ancestry as a risk amplifier
- Chronic kidney disease, inflammatory conditions, and excess alcohol in some arrhythmias
- Air pollution exposure in major Indian metros as an emerging population risk factor
How it is diagnosed
- Blood pressure series, ECG, and basic labs (lipids, glucose/HbA1c, kidney function, haemoglobin)
- Troponin and emergency ECG pathways when acute coronary syndrome is possible
- Echocardiography to assess pump function, valves, and pressures
- Stress testing, coronary CT angiography, or invasive angiography as indicated
- Ankle-brachial index for suspected peripheral artery disease
- Holter or event monitors for intermittent palpitations or AF detection
- Risk scoring plus clinical judgment - not cholesterol alone - to decide prevention intensity
Treatment & management
- Emergency reperfusion and stroke pathways when minutes matter - do not “wait and see” at home
- Guideline-directed medical therapy: antiplatelets, high-intensity statins, BP agents, beta-blockers, ARNI/ACE/ARB, SGLT2i, anticoagulants as indicated
- Cardiac rehabilitation and graded supervised exercise after events
- Smoking cessation support - the single best reversible vascular intervention for smokers
- Diabetes and weight management tightly integrated with cardiology goals
- Sleep apnoea treatment when present; limit excess alcohol
- Device therapy or procedures when medicines and lifestyle are not enough
- Medication adherence systems (pill boxes, phone reminders) - most benefit is lost when tablets stop quietly
Prevention
- Know BP, LDL, and glucose by age 30–35 if South Asian or with family history - earlier if symptomatic
- Mediterranean/DASH-style patterns adapted to dal, vegetables, fish, yoghurt, controlled oil, fewer deep-fried snacks
- Daily movement goals realistic for heat: mall walking, early outdoor walks, gym, swimming
- Never ignore new exertional chest symptoms after age 35–40 in high-risk groups
What drives it, and what you can change
Sleep is the lever most people underuse. Short or fragmented sleep, and untreated obstructive sleep apnoea, raise inflammatory markers on their own - and both are common and treatable in India and the Gulf.
Movement matters more than intensity: regular walking plus two short strength sessions a week lowers inflammatory markers, protects function, and is realistic in heat and in small flats.
Diet pattern beats individual "anti-inflammatory" foods: enough protein, high fibre, more whole plants, fewer sugary drinks and ultra-processed snacks, with cooking-oil awareness in Indian and Gulf kitchens.
Where excess visceral fat is present it is worth addressing, because visceral fat is metabolically active tissue that raises inflammatory markers directly. A realistic target for many adults is 5–10% body-weight reduction over months, with muscle protected by adequate protein and resistance training. The aim is lower inflammation and better function - not a number on a scale.
Other hidden drivers worth asking about: gum disease, untreated gut inflammation, thyroid disease, smoking, alcohol, chronic stress, and some medicines (steroids among them).
Living with it day to day
- Carry an updated medicine list and allergy list in your phone for emergencies
- Learn the difference between stable effort angina and unstable rest pain
- After stents or bypass, dual antiplatelet timing is critical - do not stop without cardiology advice
- Plan travel insurance and medicine supply for long trips between India and the Gulf
When to seek care
- Emergency (India 112 / UAE 999): crushing chest pain, stroke FAST signs, severe breathlessness, fainting with chest pain
- Same day: new rest angina, blackouts, rapidly worsening swelling or orthopnoea
- Scheduled: risk-factor review if you have diabetes + hypertension + family heart disease
Outlook
Cardiovascular outlook hinges on how early risk is controlled and whether an acute event has already occurred. After a heart attack or diagnosis of atrial Fibrillation, secondary prevention medicines plus lifestyle change dramatically cut recurrence risk. Untreated high BP, LDL, diabetes, and smoking drive much worse trajectories. Ask your cardiology or primary team what “on target” means for you.
India & UAE focus
India: Atrial Fibrillation contributes to the country’s dual burden of disease. Use qualified allopathic clinicians for diagnosis; if you also use AYUSH systems, disclose every product to avoid herb–drug interactions and heavy-metal exposures reported with some unregulated preparations. Public and private labs are widely available in cities - insist on follow-up, not only PDF reports.
UAE: High obesity and diabetes prevalence, multinational guidelines in tertiary hospitals, and strong private primary care make atrial Fibrillation both common and treatable. Summer heat requires indoor activity plans. Health insurance formularies differ - adherence support matters when co-pays change.
Shared practicalities: Ramadan and festival seasons need proactive medicine and meal planning; family kitchens decide oil and sugar more than any app; counterfeit weight-loss and sexual medicines are a regional consumer risk - use licensed pharmacies only.
Common questions
What is Atrial Fibrillation in simple terms?
Is Atrial Fibrillation chronic?
Is Atrial Fibrillation linked to chronic inflammation?
Why do I also have fatigue?
Does body weight affect Atrial Fibrillation?
What tests should I ask for?
What are the best treatments?
When is Atrial Fibrillation an emergency?
How is care different for Indian and UAE patients?
Related conditions
Sources
This guide is written against the following published guidance. Where a figure is cited, follow the source for the current version - guidance changes.
- WHO - Cardiovascular diseasesWorld Health Organization
- World Health Organization - Noncommunicable diseasesWorld Health Organization
- NICE clinical guidanceNational Institute for Health and Care Excellence (UK)
- NHS Health A-ZNHS England
- ICMR-INDIAB national study on diabetes and metabolic NCDs in IndiaIndian Council of Medical Research
- UAE Ministry of Health and PreventionMoHAP, United Arab Emirates